Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013


Gamougam, K; Daugla, DM; Toralta, J; Ngadoua, C; Fermon, F; Page, A.-, L; Djingarey, MH; Caugant, DA; Manigart, O; Trotter, CL; Stuart, JM; Greenwood, BM; (2015) Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013. Emerging infectious diseases, 21 (1). pp. 115-118. ISSN 1080-6040 DOI: 10.3201/eid2101.140256

[img] Text - Published Version
License:

Download (510kB)

Abstract

In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Disease Control
Research Centre: Centre for Maternal, Reproductive and Child Health (MARCH)
Vaccine Centre
PubMed ID: 25536336
Web of Science ID: 347503700020
URI: http://researchonline.lshtm.ac.uk/id/eprint/2124479

Statistics


Download activity - last 12 months
Downloads since deposit
166Downloads
322Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item